Summary of medicine characteristics - HYDROGEN PEROXIDE SOLUTION 9% 30 VOLS
1 NAME OF THE MEDICINAL PRODUCT
Hydrogen Peroxide Solution 9% 30 Vols
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Hydrogen peroxide aqueous solution 35% w/w HSE 22.5% v/v.
3 PHARMACEUTICAL FORM
Solution.
4 CLINICAL PARTICULARS
4.1 Therapeutic indications
1. As a mild disinfectant for minor cuts, wounds and skin ulcers.
2. As a mouthwash or gargle.
4.2. Posology and Method of Administration
Topical.
1. As a disinfectant:
Use as required. Dress the wound with cotton wool soaked in a solution of equal parts of peroxide and water.
As a disinfectant this product is suitable for use by adults, children and the elderly.
2. As a mouthwash or gargle:
Dilute one part of peroxide to eight parts of water. Rinse the mouth for two to three minutes. This may be repeated up to three times daily.
As a mouthwash or gargle the product is suitable for use by adults, children over 12 years and the elderly. Due to the risk of swallowing it should only be used by younger children under the instruction of a doctor.
4.3 Contraindications
Hypersensitivity to any of the ingredients
Not for use in closed body cavities or on surgical wounds due to the risk of oxygen released into the circulation causing gas embolism.
Not for use as a disinfection agent for surgical instruments (particularly endoscopes) and as an enema.
4.4. Special warnings and special precautions for use
For external use only.
Keep all medicines away from children.
Not for use in closed body cavities or on surgical wounds due to risk of oxygen released into the circulation causing gas embolism.
Avoid normal skin.
Product bleaches fabric.
4.5. Interactions with other Medicaments and other forms of Interaction
None known.
4.6. Pregnancy and Lactation
All medicines should be avoided if possible during pregnancy and lactation. No evidence is available as to the safety of use of this product in these conditions.
4.7. Effects on Ability to Drive and Use Machines
None known.
4.8. Undesirable effects
Cases of gas embolism, sometimes resulting in cardiac arrest, have been reported when hydrogen peroxide has been instilled in closed body cavities or deep surgical wounds.
Strong solutions of hydrogen peroxide produce irritating burns on the skin and mucous membranes with a white eschar. The pain disappears after about 1 hour. Continued use of the product as a mouthwash may cause reversible hypertrophy of the papillae of the tongue.
Reporting of suspected adverse reactions
Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard.
4.9 Overdose
4.9 OverdoseAccidental ingestion may cause sore throat, gastric disturbances and vomiting. Sudden evolution of oxygen may cause injury by acute distension of the stomach and internal bleeding. Water may be given to drink. Ingestion of large volumes can lead to gas embolism following evolution of oxygen in the stomach.
5 PHARMACOLOGICAL PROPERTIES
5.1 Pharmacodynamic properties
Hydrogen peroxide is used as a disinfectant and deodorant. It releases oxygen when applied to tissues, the effect lasts only as long as the oxygen is being released and is of short duration. The antimicrobial effect of the liberated oxygen is reduced in the presence of organic matter. It is used to cleanse wounds and ulcers in concentrations of up to 6%. Adhering and blood-soaked dressings may be released by the application of a solution of hydrogen peroxide.
A 1.5% solution has been used as a mouthwash in the treatment of acute stomatitis and as a deodorant gargle.
5.2. Pharmacokinetic Properties
No further information available.
5.3. Preclinical Safety Data
5.3. Preclinical Safety DataNone.
6. PHARMACEUTICAL PARTICULARS
6.1. List of Excipients
Phosphoric acid BP, phenacetin BP 1973, purified water BP.
6.2. Incompatibilities
Incompatible with reducing agents including organic matter and oxidisable substances and with alkalis, iodides, permanganates and other stronger oxidising agents. Its decomposition is increased by metallic salts, light, agitation, heat and metals.
6.3 Shelf life
24 months unopened.
Use within 28 days of first opening
6.4. Special Precautions for Storage
Store below 25°C.
Protect from light.
6.5. Nature and contents of container
200ml: Round amber glass bottle with white 28mm cap with Tamper Evident band and EPE/Saranex Liner.
6.6. Instruction for Use/Handling and Disposal
None.
7.
8.
L.C.M. Limited
Linthwaite Laboratories
Huddersfleld
HD7 5QH
PL 12965/0017
9. DATE OF FIRST AUTHORISATION/RENEWAL OF AUTHORISATION
27/8/1993 / 18/11/1998, 06/09/2000